Prescribing Information Forxiga® (dapagliflozin) Great Britain

Adverse Event Reporting

Astrazeneca

Contact Us

Janrain Redirect Login
AZ Employee Login
  • EN
  • Fr
Logo test product
  • test top level 1
    • test 2nd level 1
      • FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
      • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
      • testtesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttest
    • 2nd level 2
      • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
        • FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
        • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
        • test
    • 2nd level 3
      • 3rd level folder
        • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
          • FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
          • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
          • testtesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttest
    • View All Medicines
  • test
  • test top level 1
  • testing 5th menu
    • CVRM & Süd απευθύνεται
      • Breast Cancer
        • Lynparza Breast
        • Truqap Breast
      • Lung Cancer
        • NSCLC
          • Tagrisso in NSCLC
          • Imfinzi in NSCLC
        • SCLC
      • Blood Cancer
        • Calquence Blood
      • Ovarian Cancer
        • Lynparza Ovarian
    • 2nd level
      • Type 2 diabetes
      • Heart failure
      • Chronic kidney disease
      • Hyperkalaemia
    • 3rd level 3rd level 3rd level 3rd level 3rd level
      • Breast Cancer
        • item 0
        • item 1
      • Hematology
      • Liver Cancer
      • Biliary Tract Cancer
      • Lung Cancer
        • Tagrisso® (Osimertinib)
        • test 5th level FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
        • test-pr
      • Mesothelioma
      • Ovarian Cancer
      • Endometrial Cancer
      • Cervical Cancer
      • Prostate Cancer
      • Bladder Cancer
      • Gastric Cancer
      • Head and Neck
      • Pancreatic Cancer
    • 4th test tes ttest test test test tes ttest test test test tes ttest test test test tes ttest test test
      • 3rd level link
      • news in 3rd level
      • 3rd level folder
        • 4th level folder oncology
          • 5th level oncology - news
          • 5th level oncology - cvrm
        • level 4 link oncology - lung page
        • level 4 link in oncology - breast page
    • test 5 test tes ttest test test test tes ttest test test test tes ttest test test
      • Breast Cancer
      • Hematology
      • Liver Cancer
      • Biliary Tract Cancer
      • Lung Cancer
      • Mesothelioma
      • Ovarian Cancer
      • Endometrial Cancer
      • Cervical Cancer
      • Prostate Cancer
      • Bladder Cancer
      • Gastric Cancer
      • Head and Neck
      • Pancreatic Cancer
      • FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
        • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
          • FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
          • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
          • testtesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttesttest
          • test4
          • test5
          • test6
          • test7
          • test8
          • test9
          • test10
    • test 6
      • 3rd level link
      • news in 3rd level
      • 3rd level folder
        • 4th level folder oncology
          • 5th level oncology - news
          • 5th level oncology - cvrm
        • level 4 link oncology - lung page
        • level 4 link in oncology - breast page
    • test 7
      • 3rd level cvrm folder
        • 4th level folder
          • link1
          • link2
          • link3
          • link4
          • link5
          • link6
          • link7
          • link8
          • link9
          • link10
    • 8
    • test test test test test test test test etsttest test test test test test test test etst
    • View all medicines
Log

  • User
  • Login

Login

Don’t have an account?


Register here

Please enter valid email id!
Please enter valid password!

Verify your email address before accessing the portal

Unregistered user

Already registered user. Log in with your existing password

Credentials provided invalid

Incorrect data entered. Check the data entered before sending the request

The values ​​entered do not match (too long or too short)

Mandatory fields not filled in

Mandatory fields not filled in correctly

Accept the terms and conditions of use

The user cannot be validated

User not yet validated. Try signing in after your account has been certified

The doctor cannot be validated

Incorrect password. The password does not match the current one

Email not sent

Email address is not valid. Check your email address

User not validated

The authentication system is temporarily unavailable

Problems connecting to the authentication service

Operation not supported by this client

Accept the AstraZeneca terms and conditions of use

Invalid authentication type. Check the type of authentication used

The doctor cannot be validated. Incorrect password. The password does not match the current one

Remember me

Forgot Password


Invalid user id or credentials provided for authentication.

Are you an Astrazeneca employee? click here
Connessiallasalute.it

The AstraZeneca portal was created with the intention of proposing a space for digital dialogue between doctors, specialists and the company.

Privacy Notice

Cookie Notice

Prescribing Information

Important Safety Information

Legal Statement

Site Map

AstraZeneca

Contact Us

LinkedIn

Facebook

YouTube

Instagram

Twitter

A project by:

logo astrazeneca

Blueprint HCP Portal

La información contenida en este sitio web está dirigida exclusivamente a profesional sanitario facultado para prescribir o dispensar medicamentos en España (requiere una formación especializada para su correcta interpretación)

AstraZeneca promueve la prescripción de sus productos farmacéuticos en las condiciones establecidas en su ficha técnica.

NO

You are now leaving OneAZ - OFF Ramp POP UP

Quis aute iure reprehenderit in voluptate velit esse. Quo usque tandem abutere, Catilina, patientia nostra? A communi observantia non est recedendum. Plura mihi bona sunt, inclinet, amari petere vellent. Me non paenitet nullum festiviorem excogitasse ad hoc. Nihil hic munitissimus habendi senatus locus, nihil horum? Curabitur blandit tempus ardua ridiculus sed magna. Ambitioni dedisse scripsisse iudicaretur.

Continue to MyAstraZeneca

You are now leaving OneAZ - OFF Ramp POP UP

Quis aute iure reprehenderit in voluptate velit esse. Quo usque tandem abutere, Catilina, patientia nostra? A communi observantia non est recedendum. Plura mihi bona sunt, inclinet, amari petere vellent. Me non paenitet nullum festiviorem excogitasse ad hoc. Nihil hic munitissimus habendi senatus locus, nihil horum? Curabitur blandit tempus ardua ridiculus sed magna. Ambitioni dedisse scripsisse iudicaretur.

Yes